Regulatory Functions of Natural Killer Cells in Multiple Sclerosis

被引:73
作者
Gross, Catharina C. [1 ]
Schulte-Mecklenbeck, Andreas [1 ]
Wiendl, Heinz [1 ]
Marcenaro, Emanuela [2 ,3 ]
de Rosbo, Nicole Kerlero [4 ]
Uccelli, Antonio [2 ,4 ,5 ]
Laroni, Alice [2 ,4 ,5 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Munster, Germany
[2] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
[3] Univ Genoa, Dept Expt Med, Genoa, Italy
[4] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[5] IRCCS San Martino IST, Genoa, Italy
来源
FRONTIERS IN IMMUNOLOGY | 2016年 / 7卷
关键词
natural killer cells; CD56(bright) NK cells; CD56(dim) NK cells; regulatory immune cells; innate immune system; multiple sclerosis; HUMAN NK-CELLS; SECONDARY LYMPHOID ORGANS; CONTROLLED PHASE-3 TRIAL; ORAL FINGOLIMOD FTY720; SOLUBLE HLA-E; DENDRITIC-CELLS; T-CELLS; SPHINGOSINE-1-PHOSPHATE RECEPTOR; CEREBROSPINAL-FLUID; AFFERENT LYMPH;
D O I
10.3389/fimmu.2016.00606
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is increasing evidence that natural killer (NK) cells exhibit regulatory features. Among them, CD56(bright) NK cells have been suggested to play a major role in controlling T cell responses and maintaining homeostasis. Dysfunction in NK cell-mediated regulatory features has been recently described in untreated multiple sclerosis (MS), suggesting a contribution to MS pathogenesis. Moreover, biological disease-modifying treatments effective in MS apparently enhance the frequencies and/or regulatory function of NK cells, further pointing toward an immunoprotective role of NK cells in MS. Here, we summarize the current knowledge on the regulatory functions of NK cells, based on their interactions with other cells belonging to the innate compartment, as well as with adaptive effector cells. We review the more recent data reporting disruption of NK cell/T cell interactions in MS and discuss how disease-modifying treatments for MS affect NK cells.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The Role of Natural Killer (NK) Cells in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
    Xu, Wen
    Tabira, Takeshi
    ADVANCES IN NEUROIMMUNE BIOLOGY, 2011, 1 (01) : 87 - 94
  • [22] Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis
    Van Kaer, Luc
    Wu, Lan
    Parekh, Vrajesh V.
    IMMUNOLOGY, 2015, 146 (01) : 1 - 10
  • [23] Natural Killer receptors distribution in Multiple Sclerosis
    J E Martinez-Rodriguez
    M López-Botet
    Journal of Translational Medicine, 8 (Suppl 1)
  • [24] The role of regulatory T cells in multiple sclerosis
    Zozulya, Alla L.
    Wiendl, Heinz
    NATURE CLINICAL PRACTICE NEUROLOGY, 2008, 4 (07): : 384 - 398
  • [25] Natural killer cells in patients with allergic diseases
    Deniz, Gunnur
    van de Veen, Willem
    Akdis, Muebeccel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (03) : 527 - 535
  • [26] Tofacitinib Suppresses Natural Killer Cells In Vitro and In Vivo: Implications for Amyotrophic Lateral Sclerosis
    Figueroa-Romero, Claudia
    Monteagudo, Alina
    Murdock, Benjamin J.
    Famie, Joshua P.
    Webber-Davis, Ian F.
    Piecuch, Caroline E.
    Teener, Samuel J.
    Pacut, Crystal
    Goutman, Stephen A.
    Feldman, Eva L.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy
    Pedroza-Pacheco, Isabela
    Madrigal, Alejandro
    Saudemont, Aurore
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) : 222 - 229
  • [28] Bovine natural killer cells
    Boysen, Preben
    Storset, Anne K.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2009, 130 (3-4) : 163 - 177
  • [29] Adaptive immune responses mediated by natural killer cells
    Paust, Silke
    Senman, Balimkiz
    von Andrian, Ulrich H.
    IMMUNOLOGICAL REVIEWS, 2010, 235 : 286 - 296
  • [30] Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection?
    Al-Ani, Mena
    Elemam, Noha Mousaad
    Hundt, Jennifer Elisabeth
    Maghazachi, Azzam A.
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3243 - 3254